SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-041556
Filing Date
2023-05-19
Accepted
2023-05-19 16:30:47
Documents
12
Period of Report
2023-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea178889-8k_moonlake.htm   iXBRL 8-K 23642
  Complete submission text file 0001213900-23-041556.txt   196013

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mltx-20230515.xsd EX-101.SCH 2959
3 XBRL LABEL FILE mltx-20230515_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE mltx-20230515_pre.xml EX-101.PRE 22359
6 EXTRACTED XBRL INSTANCE DOCUMENT ea178889-8k_moonlake_htm.xml XML 3585
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 23940702
SIC: 2834 Pharmaceutical Preparations